1380672-96-7Relevant articles and documents
TRIAZOLE DERIVATIVES AS WNT SIGNALING PATHWAY INHIBITORS
-
Page/Page column 83-84, (2012/06/30)
The present invention relates to compounds of formula (I), to processes for their preparation, to pharmaceutical formulations containing such compounds and to their use in therapy: Such compounds find particular use in the treatment and/or prevention of conditions or diseases which are affected by over-activation of signaling in the Wnt pathway and increased presence of nuclear β-catenin. For example, these may be used in preventing and/or retarding proliferation of tumor cells and metastasis, for example carcinomas such as colon carcinomas.